Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva plus Avastin versus chemotherapy plus Avastin in first-line advanced NSCLC
2006-006359-11Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2007
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in non-small cell lung cancer (NSCLC) comparing Tarceva plus Avastin with Platinum-based chemotherapy plus Avastin (2 arms). Primary endpoint: Progression-free survival. Started Jun 2007; status: completed.
02
Drugs
erlotinibbevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-006359-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006359-11.